Phase 2 Study of Intralesional PV-10 for Metastatic Melanoma
Clinical trial NCT00521053 · COMPLETED
Trial details
- NCT number
- NCT00521053
- Sponsor
- Provectus Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2010-05-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.